Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Partially aligned: grapefruit juice plasma concentration increase is supported by the label excerpt (7.2). However, multiple interaction claims are not supported by the provided label sections (or rely on unverified “absence from the label” determinations), and several downstream outcomes (muscle weakness/fatigue/digestive issues) are not explicitly tied to grapefruit in the provided excerpts.
Category Scores
Accurate Statements
Taking Lipitor with grapefruit or grapefruit juice can lead to increased levels of the medication in the blood.
Supported: grapefruit juice components inhibit CYP3A4 and can increase atorvastatin plasma concentrations (7.2 Grapefruit Juice).
Unsupported Statements
Increased Lipitor blood levels from taking it with grapefruit or grapefruit juice may cause muscle weakness.
The provided excerpts support grapefruit juice increasing plasma concentrations (7.2) and myopathy/muscle weakness as an adverse effect class, but do not state grapefruit specifically may cause muscle weakness.
Increased Lipitor blood levels from taking it with grapefruit or grapefruit juice may cause fatigue.
Fatigue is listed as a postmarketing adverse reaction (6.2), but the provided excerpts do not attribute fatigue to the grapefruit juice interaction.
Increased Lipitor blood levels from taking it with grapefruit or grapefruit juice may cause digestive issues.
Digestive system adverse events exist in clinical adverse experiences (6.1), but the provided excerpts do not attribute digestive issues specifically to grapefruit juice.
Combining Lipitor with St. John's Wort can decrease the effectiveness of Lipitor.
No St. John's Wort interaction information is present in the provided label excerpts.
Combining Lipitor with St. John's Wort can increase the risk of side effects.
No St. John's Wort interaction information is present in the provided label excerpts.
Ginkgo biloba may increase the risk of bleeding when taken with Lipitor.
No ginkgo biloba interaction information is present in the provided label excerpts.
Garlic may increase the risk of bleeding when taken with Lipitor.
No garlic interaction information is present in the provided label excerpts.
Vitamin E may increase the risk of bleeding when taken with Lipitor.
No vitamin E interaction information is present in the provided label excerpts.
Taking coenzyme Q10 (CoQ10) (CoQ10) may not have a significant interaction with Lipitor.
The provided label excerpts do not state that CoQ10 has no significant interaction.
Lipitor can interact with certain herbal supplements and vitamins.
Partially supported in a limited sense, but the label excerpt provided only supports specific described agents (e.g., grapefruit juice and certain drug classes such as niacin/strong CYP3A4 inhibitors); it does not support the broad phrasing “certain herbal supplements and vitamins” without specifying the label-listed agents.
Contradictions
Important Omissions
No label-supported guidance was provided regarding interacting agents that increase myopathy/rhabdomyolysis risk (e.g., cyclosporine, fibric acid derivatives, niacin, certain strong CYP3A4 inhibitors) and related monitoring/withholding recommendations in skeletal muscle warning content.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several supplement-specific interaction claims are not supported by the provided label excerpts, and grapefruit downstream outcome claims (muscle weakness, fatigue, digestive issues) are not explicitly label-attributed in the provided sections. This could mislead medication-use risk interpretation.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Only the grapefruit juice plasma concentration increase claim is clearly supported by the provided label excerpts; most other supplement/herb interaction and symptom-attribution claims are not supported in the provided label text.
Suggested Improvement
Limit interaction statements to agents and outcomes explicitly described in the provided label sections (e.g., grapefruit juice increasing atorvastatin plasma concentrations; and myopathy risk being increased with specified interacting drug classes). Remove or qualify unsupported supplement-specific claims (St. John's Wort, ginkgo, garlic, vitamin E, CoQ10) unless corroborated by the full label.